ArticleJournal of experimental & clinical cancer research : CR2025

Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma.

Maria Cristina Manara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.